Emerging medical therapies in crush syndrome – progress report from basic sciences and potential future avenues
Open Access
- 1 January 2020
- journal article
- other
- Published by Taylor & Francis in Renal Failure
- Vol. 42 (1) , 656-666
Abstract
Crush injury is a disease that is commonly found in victims of earthquakes, debris flows, mine disasters, explosions, terrorist attacks, local wars, and other accidents. The complications that arise due to the crush injury inflicted on victims give rise to crush syndrome (CS). If not treated in time, the mortality rate of CS is very high. The most important measure that can be taken to reduce mortality in such situations is to immediately start treatment. However, the traditional treatment methods such as fluid resuscitation, diuresis, and hemodialysis are not feasible enough to be carried out at the disaster scene. So there is a need for developing new treatments that are efficient and convenient. Because it is difficult to diagnose in the disaster area and reach the treatment equipment and treat on time. It has become a new research needs to be directed into identifying new medical treatment targets and methods using the etiology and pathophysiological mechanisms of CS. In recent years, a large number of new anti-oxidant and anti-inflammatory drug therapies have been shown to be highly efficacious in CS rat/mouse models. Some of them are expected to become specific drugs for the emergency treatment of a large number of patients who may develop CS in the aftermath of earthquakes, wars, and other disasters in the future. Hence, we have reviewed the latest research on the medical therapy of CS as a source for anyone wishing to pursue research in this direction.Keywords
Funding Information
- Shike Hou by Science and Technology Commission (c12019048)
- Tianjin University
This publication has 114 references indexed in Scilit:
- Protective Efficacy of N-(2-Hydroxyphenyl) Acetamide against Adjuvant-Induced Arthritis in RatsBioMed Research International, 2013
- Preventive Effects of a Natural Anti-Inflammatory Agent, Astragaloside IV, on Ischemic Acute Kidney Injury in RatsEvidence-Based Complementary and Alternative Medicine, 2013
- Erythropoietin Enhances Nerve Repair in Anti-Ganglioside Antibody-Mediated Models of Immune NeuropathyPLOS ONE, 2011
- Beneficial Effects of Anisodamine in Shock Involved Cholinergic Anti-Inflammatory PathwayFrontiers in Pharmacology, 2011
- Non-erythroid effects of erythropoietinHaematologica, 2010
- Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritisArthritis Research & Therapy, 2010
- New-generation Skulachev ions exhibiting nephroprotective and neuroprotective propertiesBiochemistry (Moscow), 2010
- Dietary nitrate and nitrite modulate blood and organ nitrite and the cellular ischemic stress responseFree Radical Biology and Medicine, 2009
- Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stressVascular Health and Risk Management, 2009
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006